CCDC85B and Alzheimer disease: Interestingly, abnormal expression patterns for all of them have already been detected either in ALS patients [MIR16 (Joilin et al. 2019; Liguori et al. 2018), CCDC85B (Miller et al. 2018)] or in Alzheimer’s Disease patients (GJA5) (Ziff et al. 2022).